| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.603 | 70.606 | 68.195 | 59.455 | 60.598 | 58.607 | 96.709 | 107.453 | 88.154 | 1.927 |
| Total Income - EUR | 64.603 | 71.701 | 68.299 | 60.698 | 60.878 | 59.717 | 96.709 | 109.332 | 89.691 | 2.996 |
| Total Expenses - EUR | 61.473 | 70.346 | 67.070 | 60.043 | 62.340 | 58.782 | 86.232 | 90.188 | 82.331 | 13.222 |
| Gross Profit/Loss - EUR | 3.130 | 1.355 | 1.229 | 655 | -1.462 | 935 | 10.477 | 19.144 | 7.361 | -10.226 |
| Net Profit/Loss - EUR | 1.192 | 648 | 155 | 50 | -2.071 | 471 | 9.683 | 18.252 | 6.554 | -10.226 |
| Employees | 8 | 9 | 4 | 3 | 3 | 2 | 3 | 3 | 3 | 1 |
Check the financial reports for the company - Elisa Bio Lab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.654 | 3.680 | 3.900 | 2.275 | 2.345 | 1.199 | 6.461 | 8.397 | 6.403 | 4.422 |
| Current Assets | 7.222 | 13.201 | 9.044 | 15.165 | 15.433 | 11.444 | 25.474 | 27.612 | 3.869 | 0 |
| Inventories | 2.527 | 3.967 | 5.626 | 8.997 | 9.297 | 5.570 | 6.927 | 6.972 | 2.698 | 0 |
| Receivables | 2.733 | 8.972 | 3.388 | 5.856 | 4.430 | 4.325 | 18.436 | 20.069 | 0 | 0 |
| Cash | 1.961 | 263 | 30 | 312 | 1.706 | 1.549 | 110 | 572 | 1.171 | 0 |
| Shareholders Funds | 1.242 | 1.922 | 1.409 | 1.283 | -861 | -374 | 9.317 | 18.473 | 6.777 | -3.487 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 11.140 | 16.693 | 11.552 | 16.809 | 19.155 | 15.430 | 22.623 | 17.536 | 3.529 | 7.909 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Elisa Bio Lab S.r.l.